Complete revascularisation in patients with diabetes

摘要

Multivessel coronary artery disease (CAD) is common in clinical practice. This group of patients is heterogeneous, with differences in the location and extent of anatomical stenosis, clinical scenarios and symptoms, ventricular function and coexistent disease such as diabetes mellitus. Data on the potential benefits of complete revascularisation (CR) versus incomplete revascularisation (IR) procedures on clinical outcomes are scarce, inconclusive and much debated, with few studies examining mortality during long-term follow-ups, especially in patients with diabetes.